SERUM SURFACTANT PROTEIN-A LEVELS IN PATIENTS WITH ACUTE CARDIOGENIC PULMONARY-EDEMA AND ADULT-RESPIRATORY-DISTRESS-SYNDROME

被引：95

作者：

DOYLE, IR

NICHOLAS, TE

BERSTEN, AD

机构：

[1] FLINDERS MED CTR, SCH MED, INTENS CARE UNIT, BEDFORD PK, SA 5042, AUSTRALIA

[2] FLINDERS MED CTR, SCH MED, DEPT HUMAN PHYSIOL, BEDFORD PK, SA 5042, AUSTRALIA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1995年 / 152卷 / 01期

关键词：

D O I：

10.1164/ajrccm.152.1.7599839

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Detection of alveole-capillary damage has important implications for treatment modalities in ventilated patients. Although surfactant protein-A (SP-A) is normally only found in appreciable amounts in the lung, we describe significantly elevated concentrations in the sera of patients with acute cardiogenic pulmonary edema (median, 250 ng/ml; range, 180 to 364; n = 10) and in those with the adult respiratory distress syndrome (ARDS) (median, 378 ng/ml; range, 215 to 1,378; n = 15) relative to healthy control subjects (median, 175 ng/ml; range, 123 to 248; n = 15) and ventilated patients with no cardiorespiratory disease (median, 169 ng/ml; range, 126 to 253; n = 6) (p < 0.01, in all cases). Serum SP-A was inversely related to blood oxygenation and to static respiratory system compliance both at the time of the patient's entry into the study (p < 0.005, r(s) = -0.51, n = 31; p < 0.001, r(s) = 0.82, n = 17; respectively) and during the course of admission (p < 0.001, r(s) = -0.34, n = 168; p < 0.001, r(s) = -0.50, n = 111; respectively). In addition, we describe in detail three cases of ARDS where lung function either improved, remained static, or deteriorated. We conclude that serum SP-A is an acute indicator of lung function and alveolo-capillary membrane injury.

引用

页码：307 / 317

页数：11

共 46 条

[1] Said S.I., Avery M.E., Davis R.K., Banerjee C.M., El-Gohary M., Pulmonary surface activity in induced pulmonary edema, J. Clin. Invest., 44, pp. 458-464, (1965)
[2] Holm B.A., Notter R.H., Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity, J. Appl. Physiol., 63, pp. 1434-1442, (1987)
[3] Jefferies A.L., Kawano T., Mori S., Burger R., Effect of increased surface tension and assisted ventilation on <sup>99m</sup>Tc-DTPA clearance, J. Appl. Physiol., 64, pp. 5620-5628, (1988)
[4] Rubin P., McDonald S., Maasilta P., Finkelstein J.N., Shapiro D.L., Penney D., Gregory P.K., Serum markers for prediction of pulmonary radiation syndromes. Part 1: Surfactant apoprotein, Int. J. Radiat. Oncol. Biol. Phys., 17, pp. 553-558, (1989)
[5] Kuroki Y., Tsutahara S., Shijubo N., Takahashi H., Shiratori M., Hattori A., Honda Y., Abe S., Akino T., Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis, Am. Rev. Respir. Dis., 147, pp. 723-729, (1993)
[6] Chida S., Phelps D.S., Soll R.F., Taeusch H.W., Surfactant proteins and antisurfactant antibodies in sera from infants with respiratory distress syndrome with and without surfactant treatment, Pediatrics, 88, pp. 84-89, (1991)
[7] Strayer D.S., Merritt T.A., Lwebuga-Mukasa J., Hallman M., Surfactant-antisurfactant immune complexes in infants with respiratory distress syndrome, Am. J. Pathol., 122, pp. 353-362, (1986)
[8] Bersten A.D., Holt A.W., Vedig A.E., Skowronski G.A., Baggoley C.J., Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask, N. Engl. J. Med., 325, pp. 1825-1830, (1991)
[9] Murray J.F., Matthay M.A., Luce J.M., Flick M.R., An expanded definition of the adult respiratory distress syndrome, Am. Rev. Respir. Dis., 138, pp. 720-723, (1988)
[10] Garr K.A., Taylor A.E., Owens L.J., Guyton A.C., Pulmonary capillary pressure and filtration coefficient in the isolated perfused lung, Am. J. Physiol., 213, pp. 910-914, (1967)

← 1 2 3 4 5 →